Blog
Understanding Onyda XR: A New Option for ADHD and Beyond
One of the medications our medication management team utilizes for patients with ADHD is Onyda X — a once-daily, non-stimulant liquid formulation approved for ADHD treatment in children aged six and older.
Amitriptyline and Its Evidence-Based Uses in Mental Health
Originally developed as an antidepressant, amitriptyline has been found to be effective for multiple disorders beyond depression, including anxiety disorders, chronic pain, and sleep disturbances. By increasing levels of serotonin and norepinephrine in the brain, amitriptyline helps regulate mood, alleviate pain, and improve sleep quality.
Leucovorin (Folinic Acid) and Autism: New Hope for Improving Speech in Children
Recent research on Leucovorin suggests that this specialized form of folate can improve communication and language skills in some children with Autism Spectrum Disorder.
Navigating the First Episode of Mania: A Hopeful Perspective
Experiencing a first manic episode does not define an individual's future. With timely intervention, accurate diagnosis, and comprehensive care, many patients achieve remission and lead fulfilling lives. At Philadelphia Integrative Psychiatry, we are committed to supporting our patients through every step of their journey
The Risk of Priapism with Medications: What You Need to Know
This blog explores the medications associated with priapism, the populations most at risk, and the mechanisms behind this condition. Drawing from sources like UCSF Health, Medscape, and peer-reviewed studies, we aim to provide a comprehensive understanding of this critical issue.
Exploring Clozapine for Borderline Personality Disorder: A Potential Lifeline for High-Risk Patients
Living with borderline personality disorder (BPD) can be overwhelming, particularly for individuals grappling with severe symptoms such as recurrent self-harm, impulsivity, and suicidal ideation. One promising avenue for addressing treatment-refractory BPD is the use of clozapine.
What to Expect When Starting Psychiatric Treatment: Insights from Dr. David Danish’s Patient-Centered Approach
Starting psychiatric treatment can feel daunting, but at Philadelphia Integrative Psychiatry, Dr. David Danish and his team are dedicated to making this process as comfortable and transparent as possible.
Famotidine as an Adjunctive Treatment for Schizophrenia: A Promising Approach
Discover how famotidine, traditionally used for acid reflux, shows promise as an adjunctive treatment for schizophrenia by improving negative symptoms and enhancing patient outcomes.
Famotidine (Pepcid): A Potential Treatment for Post-COVID-19 Neuropsychiatric Symptoms
Learn how famotidine (Pepcid), traditionally used for acid reflux, is being explored as a treatment for post-COVID cognitive impairment and neuropsychiatric symptoms based on recent clinical research findings.
Hope and Recovery: Early Intervention for Schizophrenia at Philadelphia Integrative Psychiatry
Discover how early intervention programs for schizophrenia can transform lives and how Philadelphia Integrative Psychiatry offers a wraparound model for lasting recovery.
Ondansetron for Skin Excoriation Disorder: A Promising Off-Label Use
At Philadelphia Integrative Psychiatry, Dr. Danish and his team are dedicated to offering cutting-edge treatments for complex mental health conditions, including skin excoriation disorder. This often-overlooked condition can significantly impact a person's quality of life, leading to physical and emotional distress.